TABLE-A&T <6722.Q>-9-mth parent results

Related Topics

Mon Nov 9, 2009 1:09am EST 

   Nov 9 (Reuters) -
                A&T CORP
                PARENT-ONLY FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
             9 months ended  9 months ended    Year to   
               Sep 30, 2009    Sep 30, 2008    Dec 31, 2009
               LATEST          YEAR-AGO        LATEST    
               RESULTS         RESULTS         FORECAST  
 Sales               5.20            4.31            7.42   
                                 (-6.2 pct)              
 Operating            354 mln          79 mln         550 mln
                                (-82.9 pct)              
 Recurring            337 mln          64 mln         530 mln
                                (-85.7 pct)              
 Net                  453 mln           9 mln         580 mln
                                (-86.4 pct)              
 EPS                   Y72.40           Y1.59          Y92.69
 NOTE - A&T Corp engages in development and production of clinical reagents and testing equipment.
 If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.
 For latest earnings estimates made by Toyo Keizai, please
double click on 6722.TK1.
Healthcare
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.